Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 24% ± 5% | |
astrocyte | 3 studies | 23% ± 6% | |
oligodendrocyte precursor cell | 3 studies | 18% ± 2% | |
dendritic cell | 3 studies | 16% ± 0% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 29% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2000.64 | 459 / 459 | 100% | 24.25 | 1118 / 1118 |
esophagus | 100% | 1956.28 | 1445 / 1445 | 100% | 20.94 | 183 / 183 |
kidney | 100% | 2136.81 | 89 / 89 | 100% | 26.35 | 901 / 901 |
liver | 100% | 1635.08 | 226 / 226 | 100% | 16.51 | 406 / 406 |
lung | 100% | 1649.73 | 578 / 578 | 100% | 19.69 | 1155 / 1155 |
ovary | 100% | 2489.33 | 180 / 180 | 100% | 15.63 | 430 / 430 |
prostate | 100% | 2078.42 | 245 / 245 | 100% | 24.88 | 502 / 502 |
stomach | 100% | 1705.62 | 359 / 359 | 100% | 20.09 | 286 / 286 |
brain | 100% | 1771.68 | 2641 / 2642 | 100% | 22.17 | 705 / 705 |
thymus | 100% | 1992.82 | 653 / 653 | 100% | 19.79 | 604 / 605 |
intestine | 100% | 2161.56 | 966 / 966 | 100% | 21.73 | 526 / 527 |
bladder | 100% | 2633.90 | 21 / 21 | 100% | 19.50 | 502 / 504 |
uterus | 100% | 2321.12 | 170 / 170 | 100% | 19.08 | 457 / 459 |
pancreas | 99% | 1240.86 | 326 / 328 | 100% | 17.84 | 178 / 178 |
adrenal gland | 100% | 3990.43 | 258 / 258 | 99% | 19.12 | 228 / 230 |
skin | 100% | 2270.65 | 1809 / 1809 | 98% | 17.81 | 464 / 472 |
adipose | 100% | 2003.24 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.37 | 29 / 29 |
muscle | 100% | 2524.96 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2407.57 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.06 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.84 | 1 / 1 |
blood vessel | 100% | 1485.29 | 1334 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 21.25 | 79 / 80 |
heart | 98% | 1606.28 | 844 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 2147.71 | 890 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0017004 | Biological process | cytochrome complex assembly |
GO_0006783 | Biological process | heme biosynthetic process |
GO_0006784 | Biological process | heme A biosynthetic process |
GO_0007585 | Biological process | respiratory gaseous exchange by respiratory system |
GO_0070069 | Cellular component | cytochrome complex |
GO_0005746 | Cellular component | mitochondrial respirasome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0016653 | Molecular function | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor |
GO_0004129 | Molecular function | cytochrome-c oxidase activity |
GO_0020037 | Molecular function | heme binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0016627 | Molecular function | oxidoreductase activity, acting on the CH-CH group of donors |
Gene name | COX15 |
Protein name | Heme A synthase COX15 (HAS) (EC 1.17.99.9) (Cytochrome c oxidase assembly protein COX15 homolog) |
Synonyms | |
Description | FUNCTION: Catalyzes the second reaction in the biosynthesis of heme A, a prosthetic group of mitochondrial cytochrome c oxidase (CcO) . Heme A is synthesized from heme B by two sequential enzymatic reactions catalyzed by heme O synthase (HOS) and heme A synthase (HAS). HAS catalyzes the conversion of heme O to heme A by two successive hydroxylations of the methyl group at C8, in a reaction that involves matrix ferredoxin and ferredoxin reductase. The first hydroxylation forms heme I, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme A (By similarity). . |
Accessions | Q7KZN9 ENST00000016171.6 [Q7KZN9-1] ENST00000370483.9 [Q7KZN9-2] |